Bodhi Tree Biotechnology Inc (BDTB) Revenue (2024 - 2026)

Bodhi Tree Biotechnology (BDTB) has reported Revenue for 3 consecutive years, with $10000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Revenue changed N/A year-over-year to $10000.0 in Q2 2026; TTM through Jun 2026 was $22000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $17000.0, down 51.43% from the prior year.
• Revenue was $10000.0 for Q2 2026 at Bodhi Tree Biotechnology, down from $12000.0 in the prior quarter.
• Over five years, Revenue peaked at $12000.0 in Q3 2025 and troughed at $5000.0 in Q4 2024.
• A 3-year average of $9000.0 and a median of $10000.0 in 2026 frame the typical range for Revenue.